122 related articles for article (PubMed ID: 22555461)
21. Prediction and validation of the distinct dynamics of transient and sustained ERK activation.
Sasagawa S; Ozaki Y; Fujita K; Kuroda S
Nat Cell Biol; 2005 Apr; 7(4):365-73. PubMed ID: 15793571
[TBL] [Abstract][Full Text] [Related]
22. Computational design, chemical synthesis, and biological evaluation of a novel ERK inhibitor (BL-EI001) with apoptosis-inducing mechanisms in breast cancer.
Liu B; Fu L; Zhang C; Zhang L; Zhang Y; Ouyang L; He G; Huang J
Oncotarget; 2015 Mar; 6(9):6762-75. PubMed ID: 25742792
[TBL] [Abstract][Full Text] [Related]
23. Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways.
Wang H; Su X; Fang J; Xin X; Zhao X; Gaur U; Wen Q; Xu J; Little PJ; Zheng W
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30213025
[TBL] [Abstract][Full Text] [Related]
24. Positive feedback induces switch between distributive and processive phosphorylation of Hog1.
Mosbacher M; Lee SS; Yaakov G; Nadal-Ribelles M; de Nadal E; van Drogen F; Posas F; Peter M; Claassen M
Nat Commun; 2023 Apr; 14(1):2477. PubMed ID: 37120434
[TBL] [Abstract][Full Text] [Related]
25. Signaling through the neuropeptide GPCR PAC₁ induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor.
Emery AC; Eiden LE
FASEB J; 2012 Aug; 26(8):3199-211. PubMed ID: 22532442
[TBL] [Abstract][Full Text] [Related]
26. Regulation of GCL activity and cellular glutathione through inhibition of ERK phosphorylation.
Chen ZH; Saito Y; Yoshida Y; Noguchi N; Niki E
Biofactors; 2008; 33(1):1-11. PubMed ID: 19276532
[TBL] [Abstract][Full Text] [Related]
27. A kinetic model of ERK cyclic pathway on substrate control.
Hirashima T
Math Biosci; 2012 Oct; 239(2):207-12. PubMed ID: 22705338
[TBL] [Abstract][Full Text] [Related]
28. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
29. When More Is Less: Dual Phosphorylation Protects Signaling Off State against Overexpression.
Witzel F; Blüthgen N
Biophys J; 2018 Oct; 115(7):1383-1392. PubMed ID: 30217381
[TBL] [Abstract][Full Text] [Related]
30. Pharmacology of alpha7 nicotinic acetylcholine receptor mediated extracellular signal-regulated kinase signalling in PC12 cells.
El Kouhen R; Hu M; Anderson DJ; Li J; Gopalakrishnan M
Br J Pharmacol; 2009 Feb; 156(4):638-48. PubMed ID: 19226255
[TBL] [Abstract][Full Text] [Related]
31. Sustained activation of M-Ras induced by nerve growth factor is essential for neuronal differentiation of PC12 cells.
Sun P; Watanabe H; Takano K; Yokoyama T; Fujisawa J; Endo T
Genes Cells; 2006 Sep; 11(9):1097-113. PubMed ID: 16923128
[TBL] [Abstract][Full Text] [Related]
32. Conversion of graded phosphorylation into switch-like nuclear translocation via autoregulatory mechanisms in ERK signalling.
Shindo Y; Iwamoto K; Mouri K; Hibino K; Tomita M; Kosako H; Sako Y; Takahashi K
Nat Commun; 2016 Jan; 7():10485. PubMed ID: 26786866
[TBL] [Abstract][Full Text] [Related]
33. Mathematical modelling unveils the essential role of cellular phosphatases in the inhibition of RAF-MEK-ERK signalling by sorafenib in hepatocellular carcinoma cells.
Saidak Z; Giacobbi AS; Louandre C; Sauzay C; Mammeri Y; Galmiche A
Cancer Lett; 2017 Apr; 392():1-8. PubMed ID: 28161506
[TBL] [Abstract][Full Text] [Related]
34. Bayesian analysis of dynamic phosphoproteomic data identifies protein kinases mediating GPCR responses.
Leo KT; Chou CL; Yang CR; Park E; Raghuram V; Knepper MA
Cell Commun Signal; 2022 Jun; 20(1):80. PubMed ID: 35659261
[TBL] [Abstract][Full Text] [Related]
35. Identification of G2/M targets for the MAP kinase pathway by functional proteomics.
Roberts EC; Hammond K; Traish AM; Resing KA; Ahn NG
Proteomics; 2006 Aug; 6(16):4541-53. PubMed ID: 16858730
[TBL] [Abstract][Full Text] [Related]
36. Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt.
Van Kanegan MJ; Adams DG; Wadzinski BE; Strack S
J Biol Chem; 2005 Oct; 280(43):36029-36. PubMed ID: 16129692
[TBL] [Abstract][Full Text] [Related]
37. Temporal perturbation of ERK dynamics reveals network architecture of FGF2/MAPK signaling.
Blum Y; Mikelson J; Dobrzyński M; Ryu H; Jacques MA; Jeon NL; Khammash M; Pertz O
Mol Syst Biol; 2019 Nov; 15(11):e8947. PubMed ID: 31777174
[TBL] [Abstract][Full Text] [Related]
38. A targeted proteomics approach to the quantitative analysis of ERK/Bcl-2-mediated anti-apoptosis and multi-drug resistance in breast cancer.
Yang T; Xu F; Sheng Y; Zhang W; Chen Y
Anal Bioanal Chem; 2016 Oct; 408(26):7491-503. PubMed ID: 27510278
[TBL] [Abstract][Full Text] [Related]
39. Quantification of ERK Kinase Activity in Biological Samples Using Differential Sensing.
Zamora-Olivares D; Kaoud TS; Zeng L; Pridgen JR; Zhuang DL; Ekpo YE; Nye JR; Telles M; Anslyn EV; Dalby KN
ACS Chem Biol; 2020 Jan; 15(1):83-92. PubMed ID: 31775004
[TBL] [Abstract][Full Text] [Related]
40. A compendium of ERK targets.
Ünal EB; Uhlitz F; Blüthgen N
FEBS Lett; 2017 Sep; 591(17):2607-2615. PubMed ID: 28675784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
